As of January 4th, we have signed an annual CRO agreement with Sun Bio Inc. for non-clinical efficacy testing and toxicity testing services for drugs under development.
Through this agreement, we will maintain research collaboration from the preclinical phase through to clinical trials for PEG drugs being developed by Sun Bio, and use this as an opportunity to deepen cooperation in drug and product development based on mutual trust and good faith.
This collaboration was established on the basis of trust in RudaCure's efficacy testing and toxicity systems. RudaCure is currently conducting efficacy verification, pharmacokinetic studies, and toxicity testing for drugs from Sun Bio, Seoul National University J-MAX, dental product developer ODS, Daewoong Pharmaceutical, and Vivozon.